Therapeutic experience

44 distinct indications across 22 therapeutic areas. Counts below are country engagements from our register.

Ovarian, uterine serous carcinoma, melanoma, NSCLC, gastric and oesophageal adenocarcinoma, advanced solid tumours, folate-receptor targets

Ulcerative colitis, ulcerative colitis of the rectum, Crohn's disease, inflammatory bowel disease

Rheumatoid arthritis, psoriatic arthritis, juvenile RA, osteoarthritis

Chronic kidney disease, anaemia in dialysis patients, paediatric CKD with hyperkalaemia

Including rare haematological indications

Relapsing multiple sclerosis, myasthenia gravis, migraine prevention, focal-onset seizures, negative symptoms of schizophrenia

Androgenetic alopecia (266 screened, 236 randomised), moderate-to-severe atopic dermatitis

Idiopathic pulmonary fibrosis, drug-resistant pulmonary tuberculosis, COVID-19 and respiratory infections, complicated urinary tract infection

Acute coronary syndrome, chronic hepatitis delta, endocrinology, allergology, ENT, burn wounds, anaesthesiology and pain, healthy volunteers

Do not see your indication? Ask us — we will tell you the nearest study we have run.